City

Ashkelon (1)

Doha (1)

Durham (1)

Louisville (1)

Springfield (1)

Zrifin (1)

Condition

Anemia of End Stage Renal Disease (3)

Overall Status

Active, not recruiting (1)

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

phase 4 (1)

Sponsor

Aevi Genomic Medicine, LLC, a Cerecor company (1)

Hamad Medical Corporation (1)

University of Louisville (1)

Collaborator

Medgenics Medical Israel Ltd. (1)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Intervention

darbepoetin alfa (1)

epoetin alpha or beta (epoetin group) (1)

mdgn201 targtepo (1)

methoxy polyethylene glycol-epoetin beta (1)

specimen collection (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Observational (1)

anemia of end stage renal disease

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Erythropoietin-Iron Interaction in Anemia of Renal Disease

Active, not recruiting

Anemia of End Stage Renal Disease

Specimen collection

Louisville, Kentucky
+2 more

Jul 1, 2021

Anemia of End Stage Renal Disease Trial in Ashkelon, Zrifin (MDGN201 TARGTEPO)

Terminated

Has Results

Anemia of End Stage Renal Disease

MDGN201 TARGTEPO

Ashkelon, Israel
+1 more

Dec 18, 2017

Anemia of End Stage Renal Disease Trial in Doha (Epoetin alpha or beta (Epoetin group), Darbepoetin alfa, Methoxy polyethylene

Completed

Anemia of End Stage Renal Disease

Epoetin alpha or beta (Epoetin group)
+2 more

Doha, Qatar

Fahd Bin Jassem Dialysis Centre

Sep 12, 2017